Kuala Lumpur - Delayed Quote • MYR
Sunzen Biotech Berhad (0148.KL)
At close: April 26 at 4:43 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
819.3950
-32,153.6050
-16,359.1480
7,203.9140
Investing Cash Flow
-1,416.6700
-925.6700
14,976.8290
932.8350
Financing Cash Flow
-1,754.1680
-1,992.1680
9,657.3900
-1,859.5320
End Cash Position
21,970.5570
11,674.3240
46,669.4500
38,392.6480
Capital Expenditure
-1,011.1480
-2,185.1480
-2,400.7340
-1,159.0210
Issuance of Capital Stock
102.8530
1,221.8530
23,148.7670
--
Repayment of Debt
-123.9440
-125.9440
-10,006.8180
-822.3010
Repurchase of Capital Stock
-1,200.2070
-2,000.2070
--
--
Free Cash Flow
-191.7530
-34,338.7530
-18,759.8820
6,044.8930
12/31/2020 - 10/8/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade